FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323806513> ?p ?o ?g. }

• W4323806513 endingPage "e233068" @default.
• W4323806513 startingPage "e233068" @default.
• W4323806513 abstract "Importance It remains unclear whether comorbidities in patients with retinal artery occlusion (RAO), a rare retinal vascular disorder, differ by subtype and whether mortality is higher. Objective To examine the nationwide incidence of clinically diagnosed, nonarteritic RAO, causes of death, and mortality rate in patients with RAO compared with that in the general population in Korea. Design, Setting, and Participants This retrospective, population-based cohort study examined National Health Insurance Service claims data from 2002 to 2018. The population of South Korea was 49 705 663, according to the 2015 census. Data were analyzed from February 9, 2021, to July 30, 2022. Main Outcomes and Measures The nationwide incidence of any RAO, including central RAO (CRAO; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] code, H34.1) and noncentral RAO (other RAO; ICD-10 code, H34.2) was estimated using National Health Insurance Service claims data from 2002 to 2018, with 2002 to 2004 as the washout period. Furthermore, the causes of death were evaluated and the standardized mortality ratio was estimated. The primary outcomes were the incidence of RAO per 100 000 person-years and the standardized mortality ratio (SMR). Results A total of 51 326 patients with RAO were identified (28 857 [56.2%] men; mean [SD] age at index date: 63.6 [14.1] years). The nationwide incidence of any RAO was 7.38 (95% CI, 7.32-7.44) per 100 000 person-years. The incidence rate of noncentral RAO was 5.12 (95% CI, 5.07-5.18), more than twice that of CRAO (2.25 [95% CI, 2.22-2.29]). Mortality was higher in patients with any RAO than in the general population (SMR, 7.33 [95% CI, 7.15-7.50]). The SMR for CRAO (9.95 [95% CI, 9.61-10.29]) and for noncentral RAO (5.97 [95% CI, 5.78-6.16]) showed a tendency toward a gradual decrease with increasing age. The top 3 causes of death in patients with RAO were diseases of the circulatory system (28.8%), neoplasms (25.1%), and diseases of the respiratory system (10.2%). Conclusions and Relevance This cohort study found that the incidence rate of noncentral RAO was higher than that of CRAO, whereas SMR was higher for CRAO than noncentral RAO. Patients with RAO show higher mortality than the general population, with circulatory system disease as the leading cause of death. These findings suggest that it is necessary to investigate the risk of cardiovascular or cerebrovascular disease in patients newly diagnosed with RAO." @default.
• W4323806513 created "2023-03-11" @default.
• W4323806513 creator A5016550390 @default.
• W4323806513 creator A5035490395 @default.
• W4323806513 creator A5036927654 @default.
• W4323806513 creator A5040992395 @default.
• W4323806513 creator A5048799846 @default.
• W4323806513 creator A5068357228 @default.
• W4323806513 creator A5087770537 @default.
• W4323806513 creator A5088116135 @default.
• W4323806513 creator A5090076104 @default.
• W4323806513 date "2023-03-10" @default.
• W4323806513 modified "2023-10-03" @default.
• W4323806513 title "Incidence of Retinal Artery Occlusion and Related Mortality in Korea, 2005 to 2018" @default.
• W4323806513 cites W1531488791 @default.
• W4323806513 cites W1585570659 @default.
• W4323806513 cites W1773968258 @default.
• W4323806513 cites W1971502700 @default.
• W4323806513 cites W1971835723 @default.
• W4323806513 cites W1973151657 @default.
• W4323806513 cites W1979273852 @default.
• W4323806513 cites W2022964202 @default.
• W4323806513 cites W2023404555 @default.
• W4323806513 cites W2033758703 @default.
• W4323806513 cites W2045747825 @default.
• W4323806513 cites W2046179216 @default.
• W4323806513 cites W2058739809 @default.
• W4323806513 cites W2079776686 @default.
• W4323806513 cites W2090160251 @default.
• W4323806513 cites W2092606650 @default.
• W4323806513 cites W2121180003 @default.
• W4323806513 cites W2121844172 @default.
• W4323806513 cites W2125421073 @default.
• W4323806513 cites W2126203633 @default.
• W4323806513 cites W2132798093 @default.
• W4323806513 cites W2136159682 @default.
• W4323806513 cites W2222722988 @default.
• W4323806513 cites W2275737843 @default.
• W4323806513 cites W2416911783 @default.
• W4323806513 cites W2548895465 @default.
• W4323806513 cites W2778498375 @default.
• W4323806513 cites W2802028395 @default.
• W4323806513 cites W2888270632 @default.
• W4323806513 cites W2905456986 @default.
• W4323806513 cites W2969983612 @default.
• W4323806513 cites W3011282565 @default.
• W4323806513 cites W3088167896 @default.
• W4323806513 cites W3090840297 @default.
• W4323806513 cites W3111867831 @default.
• W4323806513 cites W3118600281 @default.
• W4323806513 cites W3126529723 @default.
• W4323806513 cites W3172449186 @default.
• W4323806513 cites W3182476945 @default.
• W4323806513 cites W3197233575 @default.
• W4323806513 cites W4220831042 @default.
• W4323806513 cites W4243740842 @default.
• W4323806513 cites W4283641910 @default.
• W4323806513 cites W4292528167 @default.
• W4323806513 cites W4292939514 @default.
• W4323806513 cites W4293773714 @default.
• W4323806513 cites W4294316490 @default.
• W4323806513 doi "https://doi.org/10.1001/jamanetworkopen.2023.3068" @default.
• W4323806513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36897587" @default.
• W4323806513 hasPublicationYear "2023" @default.
• W4323806513 type Work @default.
• W4323806513 citedByCount "1" @default.
• W4323806513 countsByYear W43238065132023 @default.
• W4323806513 crossrefType "journal-article" @default.
• W4323806513 hasAuthorship W4323806513A5016550390 @default.
• W4323806513 hasAuthorship W4323806513A5035490395 @default.
• W4323806513 hasAuthorship W4323806513A5036927654 @default.
• W4323806513 hasAuthorship W4323806513A5040992395 @default.
• W4323806513 hasAuthorship W4323806513A5048799846 @default.
• W4323806513 hasAuthorship W4323806513A5068357228 @default.
• W4323806513 hasAuthorship W4323806513A5087770537 @default.
• W4323806513 hasAuthorship W4323806513A5088116135 @default.
• W4323806513 hasAuthorship W4323806513A5090076104 @default.
• W4323806513 hasBestOaLocation W43238065131 @default.
• W4323806513 hasConcept C102803821 @default.
• W4323806513 hasConcept C120665830 @default.
• W4323806513 hasConcept C121332964 @default.
• W4323806513 hasConcept C126322002 @default.
• W4323806513 hasConcept C144024400 @default.
• W4323806513 hasConcept C149923435 @default.
• W4323806513 hasConcept C167135981 @default.
• W4323806513 hasConcept C179755657 @default.
• W4323806513 hasConcept C187212893 @default.
• W4323806513 hasConcept C207103383 @default.
• W4323806513 hasConcept C2777654188 @default.
• W4323806513 hasConcept C2908647359 @default.
• W4323806513 hasConcept C44249647 @default.
• W4323806513 hasConcept C45827449 @default.
• W4323806513 hasConcept C61511704 @default.
• W4323806513 hasConcept C71924100 @default.
• W4323806513 hasConcept C72563966 @default.
• W4323806513 hasConcept C99454951 @default.
• W4323806513 hasConceptScore W4323806513C102803821 @default.
• W4323806513 hasConceptScore W4323806513C120665830 @default.

• next